BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 25187512)

  • 61. [A feasibility research of minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF) using hybrid internal fixation for recurrent lumbar disc herniation].
    Mao KY; Wang Y; Xiao SH; Zhang YG; Liu BW; Wang Z; Zhang XF; Cui G; Zhang XS; Li P; Mao KZ
    Zhonghua Wai Ke Za Zhi; 2013 Aug; 51(8):723-7. PubMed ID: 24252680
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Changes in back pain after percutaneous endoscopic lumbar discectomy and annuloplasty for lumbar disc herniation: a prospective study.
    Choi KC; Kim JS; Kang BU; Lee CD; Lee SH
    Pain Med; 2011 Nov; 12(11):1615-21. PubMed ID: 21992543
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Lumbar total disc replacement. Short-term results].
    Matějka J; Zeman J; Matějka T; Nepraš P; Belatka J
    Acta Chir Orthop Traumatol Cech; 2012; 79(1):37-40. PubMed ID: 22405547
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The influence of pain sensitivity on the symptom severity in patients with lumbar spinal stenosis.
    Kim HJ; Suh BG; Lee DB; Lee GW; Kim DW; Kang KT; Chang BS; Lee CK; Yeom JS
    Pain Physician; 2013; 16(2):135-44. PubMed ID: 23511680
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical effectiveness of percutaneous adhesiolysis using Navicath for the management of chronic pain due to lumbosacral disc herniation.
    Lee JH; Lee SH
    Pain Physician; 2012; 15(3):213-21. PubMed ID: 22622905
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of the intradiscal implantation of stromal vascular fraction plus platelet rich plasma in patients with degenerative disc disease.
    Comella K; Silbert R; Parlo M
    J Transl Med; 2017 Jan; 15(1):12. PubMed ID: 28086781
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cryopreserved bone marrow aspirate concentrate as a cell source for the colony-forming unit fibroblast assay.
    Berger DR; Aune ET; Centeno CJ; Steinmetz NJ
    Cytotherapy; 2020 Sep; 22(9):486-493. PubMed ID: 32565131
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Office-Based Mesenchymal Stem Cell Therapy for the Treatment of Musculoskeletal Disease: A Systematic Review of Recent Human Studies.
    Law L; Hunt CL; van Wijnen AJ; Nassr A; Larson AN; Eldrige JS; Mauck WD; Pingree MJ; Yang J; Muir CW; Erwin PJ; Bydon M; Qu W
    Pain Med; 2019 Aug; 20(8):1570-1583. PubMed ID: 30597057
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The Analgesic Efficacy of Intradiscal Injection of Bone Marrow Aspirate Concentrate and Culture-Expanded Bone Marrow Mesenchymal Stromal Cells in Discogenic Pain: A Systematic Review.
    Her YF; Kubrova E; Martinez Alvarez GA; D'Souza RS
    J Pain Res; 2022; 15():3299-3318. PubMed ID: 36299501
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Intraspinal Transplantation of Autologous Neurogenically-Induced Bone Marrow-Derived Mesenchymal Stem Cells in the Treatment of Paraplegic Dogs without Deep Pain Perception Secondary to Intervertebral Disk Disease.
    Besalti O; Can P; Akpinar E; Aktas Z; Elcin AE; Elcin YM
    Turk Neurosurg; 2015; 25(4):625-32. PubMed ID: 26242341
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Efficacy and safety of a novel hydrogel (HYADD4-G) in degenerative disc disease patients: a multicentric open label study.
    Mazza E; Marcia S; Mondaini F; Piras E; Giordan N; Torri T; Barbanti-Bròdano G; Parodi F
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2692-2703. PubMed ID: 32196620
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Characteristics of stromal cell precursors in patients after allogeneic bone marrow transplantation].
    Petinati NA; Shipunova IN; Bigil'deev AE; Kuz'mina LA; Saribekian RA; Gal'tseva IV; Misiurin AV; Parovichnikova EN; Savchenko VG; Drize NI
    Ter Arkh; 2013; 85(12):95-9. PubMed ID: 24640677
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Outcomes of autologous bone marrow mononuclear cells for cerebral palsy: an open label uncontrolled clinical trial.
    Nguyen LT; Nguyen AT; Vu CD; Ngo DV; Bui AV
    BMC Pediatr; 2017 Apr; 17(1):104. PubMed ID: 28403842
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Intradiscal injection of hematopoietic stem cells in an attempt to rejuvenate the intervertebral discs.
    Haufe SM; Mork AR
    Stem Cells Dev; 2006 Feb; 15(1):136-7. PubMed ID: 16522171
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Percutaneous autologous bone marrow injection for treatment of delayed and non-union of long bone: a retrospective study of 45 cases.
    Gross JB; Diligent J; Bensoussan D; Galois L; Stoltz JF; Mainard D
    Biomed Mater Eng; 2015; 25(1 Suppl):187-97. PubMed ID: 25538069
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clinical Efficacy and Safety of Human Mesenchymal Stem Cell Therapy for Degenerative Disc Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Xie B; Chen S; Xu Y; Han W; Hu R; Chen M; He R; Ding S
    Stem Cells Int; 2021; 2021():9149315. PubMed ID: 34557231
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Safety and tolerability of intrathecal delivery of autologous bone marrow nucleated cells in children with cerebral palsy: an open-label phase I trial.
    Mancías-Guerra C; Marroquín-Escamilla AR; González-Llano O; Villarreal-Martínez L; Jaime-Pérez JC; García-Rodríguez F; Valdés-Burnes SL; Rodríguez-Romo LN; Barrera-Morales DC; Sánchez-Hernández JJ; Cantú-Rodríguez OG; Gutiérrez-Aguirre CH; Gómez-De León A; Elizondo-Riojas G; Salazar-Riojas R; Gómez-Almaguer D
    Cytotherapy; 2014 Jun; 16(6):810-20. PubMed ID: 24642016
    [TBL] [Abstract][Full Text] [Related]  

  • 78. An open-label proof-of-concept study of intrathecal autologous bone marrow mononuclear cell transplantation in intellectual disability.
    Sharma A; Sane H; Gokulchandran N; Pai S; Kulkarni P; Ganwir V; Maheshwari M; Sharma R; Raichur M; Nivins S; Badhe P
    Stem Cell Res Ther; 2018 Jan; 9(1):19. PubMed ID: 29386049
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease.
    Lyra AC; Soares MB; da Silva LF; Fortes MF; Silva AG; Mota AC; Oliveira SA; Braga EL; de Carvalho WA; Genser B; dos Santos RR; Lyra LG
    World J Gastroenterol; 2007 Feb; 13(7):1067-73. PubMed ID: 17373741
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cancer risk is not increased in patients treated for orthopaedic diseases with autologous bone marrow cell concentrate.
    Hernigou P; Homma Y; Flouzat-Lachaniette CH; Poignard A; Chevallier N; Rouard H
    J Bone Joint Surg Am; 2013 Dec; 95(24):2215-21. PubMed ID: 24352775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.